TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from TYK Medicines, Inc. Class H ( (HK:2410) ) is now available.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has announced that its Board of Directors will convene on August 31, 2025. The meeting will focus on approving the interim results for the first half of 2025 and discussing the potential payment of an interim dividend. This announcement signals the company’s commitment to transparency and shareholder engagement, potentially impacting its market position and investor relations.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 4,096,991
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.21B
See more data about 2410 stock on TipRanks’ Stock Analysis page.